Laetitia Szaller

General Counsel and Head of Compliance at Egetis Therapeutics

Speaker

Laetitia brings over two decades of experience across multiple industries, with 19 years dedicated to the pharmaceutical and medical device sector. Her expertise spans multi-jurisdictional operations, including global multimillion-dollar M&A transactions, licensing agreements, and collaborative partnerships.

In her current role at Egetis Therapeutics, which she joined in December 2023, Laetitia manages the global legal and compliance functions, preparing the organization for launch in Europe and the US. She also heads the enterprise risk management and ESG function across international markets.

Previously, she led Legal Operations and Corporate Development at AM-Pharma, driving IPO readiness and commercialization, including the negotiation of a significant Japanese out-licensing agreement.

At UCB, she served as global Associate General Counsel for BD, M&A, and Antitrust, leading multi-million-dollar projects in asset divestment, licensing, and venture fund investment, while heading the Belgian R&D site's legal operations. She was recognized as Top Talent with three awards.

She represented AM-Pharma and UCB at EFPIA in Brussels, actively contributing to EU policymaking.

At Zoetis (formerly Pfizer's animal health division), she served as Legal Director for Emerging Markets, managing legal strategy across 104 countries in Europe, Africa, and the Middle East.

At Abbott Vascular, she swiftly rose from Legal Counsel to Head of Legal Department, supporting 14 countries and over 60 distributors across EMEA. Her exceptional leadership was acknowledged with the European Outstanding Achievement Award.

Beyond healthcare, she held global roles at the Carlson Rezidor Hotel Group and in the automotive division (Wabco) at American Standard, where she led negotiations on global multi-million outsourcing deals and restructured the entire EU distribution system.

Laetitia is qualified as a lawyer in both the UK and Belgium. She is a regular speaker at legal conferences addressing life sciences, antitrust, M&A, international legal strategy and leadership.